IndiaTickerLatest filing: Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2026.
ObservedCompany dossier
Jenburkt Pharmaceuticals
BSE:JENBURPH · ISIN INE354A01013
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Jenburkt Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 46.62% and public 53.38% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2026.
BSE · financial results
Observed
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Change in Registered Office Address
BSE · exchange filing
Observed
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Closure of Trading Window
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 46.62%
- Public
- 53.38%
- Employee trust
- N/A
Observed BSE shareholding XBRL